XBI

SPDR S&P Biotech ETF
A

60
*Unless otherwise stated, data provided by FactSet.

XBI Fund Description

XBI tracks an equal-weighted index of US biotechnology stocks.

XBI Factset Analytics Insight

XBI provides exposure to one of the broadest portfolios among US biotech ETFs. The fund equal-weights its portfolio, which in turn emphasizes small- and micro-caps and greatly reduces single-name risk. Thus, the weighted-average market cap is much smaller than some competitors. Unlike other funds in this segment, XBI is a pure biotech play, with relatively small pharma overlap as we see it. This highly efficient fund, which charges less than competing funds, has a history of beating its index due to revenue from securities lending. It has attracted a large asset base and trades with excellent volume. The fund’s alternative take on the space earns it a place on our Opportunities List.

XBI MSCI ESG Analytics Insight

SPDR S&P Biotech ETF has an MSCI ESG Fund Rating of B based on a score of 2.21 out of 10. The MSCI ESG Fund Rating measures the resiliency of portfolios to long-term risks and opportunities arising from environmental, social, and governance factors. ESG Fund Ratings range from best (AAA) to worst (CCC). Highly rated funds consist of companies that tend to show strong and/or improving management of financially relevant environmental, social and governance issues. These companies may be more resilient to disruptions arising from ESG events.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. SPDR S&P Biotech ETF ranks in the 3th percentile within its peer group and in the 5th percentile within the global universe of all funds covered by MSCI ESG Fund Ratings.

XBI CHARTS AND PERFORMANCE

Price Chart ($)
Total Return Chart (%)
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
COMPARE
RESET
Select ETFs to compare their performance:
PERFORMANCE [as of 06/13/19] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
XBI -2.62% -9.17% 13.90% -15.56% 13.90% 11.03% 17.86%
XBI (NAV) 3.51% -9.39% 15.37% -14.33% 15.22% 11.47% 18.05%
S&P Biotechnology Select Industry Index 3.53% -9.35% 15.45% -14.32% 15.25% 11.21% 18.05%
Thomson Reuters US Biotechnology & Medical Research -- -- -- -- -- -- --
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

XBI Top 10 Countries

XBI Top 10 Sectors

XBI Top 10 Holdings [View All]

XBI Summary Data

SPDR
01/31/06
Open-Ended Fund
0.35%
$4.03B
$418.92M
0.03%

XBI Portfolio Data

$11.71B
-16.24
4.73
0.17%
06/21/19
121

XBI Index Data

Equal
Market Cap
Thomson Reuters US Biotechnology & Medical Research

XBI Portfolio Management

0.35%
0.07%
0.11%
-0.01%

XBI Tax Exposures

20.00% / 39.60%
--
Qualified dividends
No

XBI Fund Structure

Open-Ended Fund
No
Yes
100% / 0%
N/A
N/A
Low
Daily
Cboe Book Viewer
TOP OF BOOK
LAST 10 TRADES
Bats BZX Real-time Quote -
Daily Spread
Premium/Discount
Volume

XBI Factset Analytics Block Liquidity

As of 06/14/19
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of XBI. XBI is rated a 5 out of 5.

XBI Tradability

4,969,735
$418.92M
4,647,611
$389.03M
0.03%
$0.02
-0.02%
0.37% / -0.53%
None
100.00%
50,000
92.95
0.01%
0.17%
583,679
$83.11
5

XBI Sector/Industry Breakdown


XBI
Segment Benchmark
72.98%
81.94%
11.16%
0.84%
7.23%
4.15%
1.53%
--
1.10%
0.45%
0.74%
0.16%
0.48%
--
0.15%
--

XBI Countries


XBI
Segment Benchmark
100.00%
100.00%

XBI Regions


XBI
Segment Benchmark
100.00%
100.00%

XBI Economic Development


XBI
Segment Benchmark
100.00%
100.00%

XBI Performance Statistics

0.92
1.21
1.23
1.18
0.66%
Thomson Reuters US Biotechnology & Medical Research

XBI MSCI ESG Ratings

B
2.21 / 10
4.78
2.58
0.75%
18.29%
26.87

XBI BENCHMARK COMPARISON HOLDINGS

121
141
98
45.09%

XBI BENCHMARK COMPARISON SUMMARY


XBI
Segment Benchmark
121
141
$11.71B
$27.31B
-16.24
-101.03
4.73
5.14
0.19%
0.70%
Low
High

XBI BENCHMARK COMPARISON MARKET CAP SIZE


XBI
Segment Benchmark
15.63%
45.79%
32.51%
31.39%
45.72%
20.31%
6.12%
2.51%

Options Strategies for Outcome Investing

Options allow you to customize investment outcomes. Using the strategy builders provided by Cboe Vest Technologies, you can construct some of the most common option strategies. Check out our user guide for more information on how to use the tool.

A collar strategy is a protective option strategy constructed by writing a call and buying a put with the same expiration date while being long the underlying security.